CLINICAL_TRIALS
trial_result
· 2022-08-01
Clinical Trial Update: Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer [Phase 3]
Summary
Phase 3 trial evaluating dexamethasone to reduce everolimus-induced oral stomatitis in cancer patients was terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Malignant Neoplasm | Phase 3 | Status: TERMINATED | Results posted: 2022-08-01